Mayne Pharma Group Limited is pleased to announce the commercial launch of a generic version of ORTHO-CEPT® (desogestrel and ethinyl estradiol 0.15 mg / 0.03 mg) tablets to customers in the US.
US-based Lyndra Therapeutics has revealed plans to develop a once-monthly oral contraceptive that will deliver a continuous dose of estrogen and progestin over multiple weeks.
The pharmaceutical multinational Exeltis, with a strong position in Women's Health, has received acceptance from the US Food and Drug Administration (FDA) of the filing.....